Medicine · 2016 · 15 citations · 17 references
MedicinePathobiologyPathologyAnatomic PathologyHistologyHistopathologyFibrosisHematologic DisordersHistiocytic DisordersInflammatory LesionsOrgan HistologyBraf V600 MutationsBraf V600e MutationErdheim-chester DiseaseGuided Core Needle BiopsyNon-langerhans Cell HistiocytosisPerineural FibrosisTissue Architecture Maintenance
Erdheim-Chester disease is a rare form of non-Langerhans cell histiocytosis characterized by the migration and infiltration of lipid-laden CD68, CD1a and S100 histiocytes to various target organs, which leads to the disruption of physiological tissue architecture and reactive fibrosis, and thus impairs organ function.We describe the first case of a patient with Erdheim-Chester disease with multiorgan involvement developed after 6 years from polycythemia vera diagnosis. During the follow-up, an abdominal ultrasound scan revealed the presence of dense, bilateral perinephric infiltration. A computed tomographic guided core biopsy was performed in order to identify the histological nature of this lesion, and a morphological analysis demonstrated the accumulation of foamy histiocytes surrounded by fibrosis. The BRAFV600E mutation was detected, and a diagnosis of Erdheim-Chester disease was made.The extreme rarity of Erdheim-Chester disease strongly suggests the existence of potentially common element(s) that may have contributed to the pathogenesis of both disorders. Obviously, further studies are needed to clarify the mutual roles and effects of JAK2 and BRAF mutations in this patient, as well as their possible therapeutic implications.
17
A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders
Róbert Královics, Francesco Passamonti, Andreas Buser et al. · New England Journal of Medicine · 2005 · 3.5K citations · Full text
Life Sciences, Genetics, Hematology +15
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
Srđan Verstovšek, Hagop M. Kantarjian, Ruben A. Mesa et al. · New England Journal of Medicine · 2010 · 1.2K citations · Full text
Medicine, Hematology, Pharmacology +13
European consensus on grading bone marrow fibrosis and assessment of cellularity.
Jürgen Thiele, Hans Michael Kvasnicka, Fabio Facchetti et al. · PubMed · 2005 · 770 citations
Medicine, Pathology, Hematopathology +15